Ullamari Pesonen
Professor

Professor, Institute of Biomedicine (Institute of Biomedicine)
Integrative Physiology and Pharmacology
ullamari.pesonen@utu.fi
+358 29 450 3867
Kiinamyllynkatu 10
Turku
Medisiina C
Office: C604





Areas of expertise
Drug Development; Neuropharmacology

Biography

Education and academic adjunct positions:

  • Adjunct Professor of Pharmacogenetics, University of Eastern Finland (Kuopio, Finland), 2006 -
  • PhD (Pharmacology), University of Turku (Turku, Finland) 1993
  • MSc (Biochemistry), University of Turku (Turku, Finland), 1987

Previous professional appointments and work experience:

  • 2007-2017 Principal Research Scientist, Orion Corporation/Orion Pharma, Turku, Finland
  • 2001-2006 Senior Lecturer/Associate Professor of Drug Development, University of Turku, Department of Pharmacology, Drug Development and Therapeutics, Finland
  • 2001-2002 Visiting Senior Researcher, University of Glasgow, Department of Medicine and Therapeutics (Glasgow, UK)
  • 1988-2000 Several academic positions, University of Turku, Department of Pharmacology and Clinical Pharmacology, Finland
  • 1993-1994 Visiting Fellow, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism (Bethesda, MD, USA)

On-going official duties:

  • Member of the Steering Committee on Turku Center for Disease Modeling (TCDM), 2018 -
  • Member of the Student Election Committee of Biomedicine Curriculum, 2018 -
  • Member of the Curriculum Steering Committee of Master’s Degree Programme in Biomedical Sciences, 2018 -
  • Member of the Curriculum Steering Committee of Batchelor’s Degree Programme in Biomedicine, 2018 -
  • Member of the Board of Institute of Biomedicine, University of Turku, 2016 -
  • Member of the Board of Directors of the Nordic Association for the Publication of “Basic & Clinical Pharmacology and Toxicology” (BCPT) (former Nordic Pharmacological Society), 2014-
  • Member of the Board of Drug Research Doctoral Program (DRDP), University of Turku, 2010-, Vice Director 2018 -
  • Expert Member in Finnish Market Court (civil IPR cases), 2013 - 
  • Vice President of Finnish Pharmacological Society, 2011 -




Publications
Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Neurophysiology and genetics of burning mouth syndrome (2019)
European Journal of Pain
Kolkka M., Forssell H., Virtanen A., Puhakka A., Pesonen U., Jääskeläinen S.K.
(
A1 Journal article – refereed)

1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists (2016)
Bioorganic and Medicinal Chemistry Letters
Fabritius CH, Pesonen U, Messinger J, Horvath R, Salo H, Galezowski M, Galek M, Stefanska K, Szeremeta-Spisak J, Olszak-Plachta M, Buda A, Adamczyk J, Krol M, Prusis P, Sieprawska-Lupa M, Mikulski M, Kuokkanen K, Chapman H, Obuchowicz R, Korjamo T, Jalava N, Nowak M
(
A1 Journal article – refereed)

Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure (2016)
PLoS ONE
Henriikka Salomäki-Myftari, Laura H. Vähätalo, Liisa Ailanen, Sami Pietilä, Asta Laiho, Arno Hänninen, Juha-Pekka Pursiheimo, Eveliina Munukka, Anniina Rintala, Eriika Savontaus, Ullamari Pesonen, Markku Koulu
(
A1 Journal article – refereed)

Right secondary somatosensory cortex-a promising novel target for the treatment of drug-resistant neuropathic orofacial pain with repetitive transcranial magnetic stimulation (2015)
PAIN
Lindholm P, Lamusuo S, Taiminen T, Pesonen U, Lahti A, Virtanen A, Forssell H, Hietala J, Hagelberg N, Pertovaara A, Parkkola R, Jaaskelainen S
(
A1 Journal article – refereed)

Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring (2014)
PLoS ONE
Salomäki H, Heinäniemi M, Vähätalo LH, Ailanen L, Eerola K, Ruohonen ST, Pesonen U, Koulu M.
(
A1 Journal article – refereed)

Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation (2014)
PAIN
Satu K. Jääskeläinen , Pauliina Lindholm, Tanja Valmunen, Ullamari Pesonen, Tero Taiminen, Arja Virtanen, Salla Lamusuo, Heli Forssell, Nora Hagelberg, Jarmo Hietala, Antti Pertovaara
(
A1 Journal article – refereed)

5-hydroksitryptamiini ja 5-HT-reseptoreihin vaikuttavat lääkeaineet (2013) Farmakologia ja toksikologia Pesonen U, Koulu M
(
A3 Book chapter)

Association between Neurocognitive Impairment and the Short Allele of the 5-HTT Promoter Polymorphism in Depression – A Pilot Study (2013)
Psychiatry Journal
Kalska H, Pesonen U, Lehikoinen S, Stenberg JH, Lipsanen J, Niemi-Pynttäri J, Tuunainen A
(
A1 Journal article – refereed)

Brain nor-beta-CIT Binding Is Related to the Short Term Heart Rate and Cardiac Repolarisation Interval Variability on ECG in l Homozygotes by Serotonin Transporter Gene Polymorphism (5-HTTLPR) (2013)
European Journal of Nuclear Medicine and Molecular Imaging
Kauppila E, Lipponen J, Tarvainen M, Kaurijoki S, Karhunen L, Pietilainen H, Rissanen A, Kaprio J, Pesonen U, Tiihonen J, Vanninen E
(
O2 Other)

Epilepsialääkkeet (2013) Farmakologia ja toksikologia Pesonen U
(
A3 Book chapter)

Histamiini ja histamiinireseptoreihin vaikuttavat lääkeaineet (2013) Farmakologia ja toksikologia Pesonen U
(
A3 Book chapter)

Influence of Serotonin Transporter Gene Polymorphism (5-HTTLPR Polymorphism) on the Relation between Brain 5-HT Transporter Binding and Heart Rate Corrected Cardiac Repolarization Interval (2013)
PLoS ONE
Kauppila E, Vanninen E, Kaurijoki S, Karhunen L, Pietilainen KH, Rissanen A, Tiihonen J, Pesonen U, Kaprio J
(
A1 Journal article – refereed)

Matolääkkeet ja ulkoloisten häätöön käytetyt lääkeaineet (2013) Farmakologia ja toksikologia Pesonen U
(
A3 Book chapter)

Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood (2013)
PLoS ONE
Salomaki H, Vahatalo LH, Laurila K, Jappinen NT, Penttinen AM, Ailanen L, Ilyasizadeh J, Pesonen U, Koulu M
(
A1 Journal article – refereed)

Right S2 cortex: an effective target for the treatment of neuropathic pain with transcranial magnetic stimulation (2013)
Journal of Neurology
Lindholm P, Lamusuo S, Lahti A, Pesonen U, Taiminen T, Virtanen A, Forssell H, Hietala J, Hagelberg N, Parkkola R, Jaaskelainen SK
(
O2 Other)

5-hydroksitryptamiini ja 5-HT-reseptoreihin vaikuttavat lääkeaineet (2012) Farmakologia ja toksikologia Pesonen Ullamari, Koulu Markku
(
A3 Book chapter)

Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression (2012)
Acta Neuropsychiatrica
KOEFOED P, WOLDBYE DPD, HANSEN TV, Eplov LF, Christiansen SH, MORS O, KESSING LV, WERGE T, Kaipio K, PESONEN U, FAHMY T, MELLERUP E, JAKOBSEN KD, HANSEN ES, KNUDSEN GM, Bukh JD, BOCK C, LINDBERG C, Kristensen AS, DAM H, NORDENTOFT M, Als TD, WANG AG, GETHER U, REHFELD JF, BOLWIG TG
(
A1 Journal article – refereed)

Epilepsialääkkeet. (2012) Farmakologia ja toksikologia Pesonen Ullamari
(
A3 Book chapter)

Histamiini ja histamiinireseptoreihin vaikuttavat lääkeaineet. (2012) Farmakologia ja toksikologia Pesonen Ullamari
(
A3 Book chapter)

Matolääkkeet ja ulkoloisten häätöön käytetyt lääkeaineet (2012) Farmakologia ja toksikologia Pesonen Ullamari
(
A3 Book chapter)


Last updated on 2019-16-09 at 02:23